Page last updated: 2024-09-03

tazobactam and citric acid, anhydrous

tazobactam has been researched along with citric acid, anhydrous in 1 studies

Compound Research Comparison

Studies
(tazobactam)
Trials
(tazobactam)
Recent Studies (post-2010)
(tazobactam)
Studies
(citric acid, anhydrous)
Trials
(citric acid, anhydrous)
Recent Studies (post-2010) (citric acid, anhydrous)
1,32715369411,8947834,366

Protein Interaction Comparison

ProteinTaxonomytazobactam (IC50)citric acid, anhydrous (IC50)
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
perilipin-5Homo sapiens (human)4.5885
perilipin-1Homo sapiens (human)3.708
1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform aHomo sapiens (human)4.5885

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Ankravs, MJ; Bellomo, R; Deane, AM; Rechnitzer, T; Roberts, JA; Sharrock, L; Wallis, SC1

Other Studies

1 other study(ies) available for tazobactam and citric acid, anhydrous

ArticleYear
Clearance of Piperacillin-Tazobactam and Vancomycin During Continuous Renal Replacement With Regional Citrate Anticoagulation.
    Therapeutic drug monitoring, 2023, 04-01, Volume: 45, Issue:2

    Topics: Acute Kidney Injury; Anti-Bacterial Agents; Anticoagulants; Citrates; Citric Acid; Critical Illness; Humans; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tazobactam; Vancomycin

2023